硅胶植入物乳房手术后的磁共振成像筛查:患者对美国食品药品监督管理局建议依从性的调查
该研究通过电话调查2011至2016年间接受硅胶乳房植入物的患者,评估其对美国食品药品监督管理局磁共振成像监测建议的知晓与依从情况。370例符合纳入标准者中109例同意参与,依从率为5.9%(95%CI 0.15%至28.7%)。美容与重建手术、保险状况及居住地收入中位数与依从性无显著差异。
要点
- 109例受访者中对美国食品药品监督管理局磁共振筛查建议的依从率为5.9%(95%CI 0.15%至28.7%)。
- 美容与重建手术组间依从性无差异(p=1.00;OR 0.80;95%CI 1.17至2.93)。
- 有无医疗保险(p=0.58)及居住县收入中位数是否高于所在州(p=0.33)与依从性无显著差异。
核心结论
- 小部分受访者按照美国食品药品监督管理局建议接受了磁共振成像检查。
- 低依从性凸显了当前联邦监测建议的潜在局限性。
- 需要进一步研究以更好地描述磁共振成像监测建议的依从性、识别实施障碍并确定该建议是否仍然有效。
研究设计与样本
- 检索2011年至2016年间放置硅胶乳房植入物且年龄18岁及以上患者的电子病历。
- 同意参与的患者通过电话使用标准化脚本接受调查,评估对美国食品药品监督管理局建议的知晓、是否接受磁共振成像筛查及检测障碍。
- 拒绝参与或无法联系的患者被排除。
- 收集人口统计学和手术数据,计算比值比及单样本95%置信区间,并在正态性假设下进行Fisher精确独立性检验。
- 进行多变量逻辑回归分析以检验混杂因素。
主要发现
- 370例符合纳入标准的患者中,109例同意参与。
- 对美国食品药品监督管理局建议的依从率为5.9%(95%CI 0.15%至28.7%)。
- 美容手术与重建手术患者的依从性无差异(p=1.00;OR 0.80;95%CI 1.17至2.93)。
- 有无医疗保险与依从性无差异(p=0.58)。
- 居住县家庭年收入中位数高于所在州与依从性无差异(p=0.33)。
关键数值与推荐
- 美国食品药品监督管理局建议硅胶乳房植入物女性接受磁共振成像监测以检测无症状破裂。
- 依从率5.9%(95%CI 0.15%至28.7%)。
- 美容与重建手术比较:p=1.00;OR 0.80;95%CI 1.17至2.93。
- 有无医疗保险比较:p=0.58。
- 居住县收入中位数与所在州比较:p=0.33。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The U.S. Food and Drug Administration recommends women with silicone breast implants undergo magnetic resonance imaging surveillance to detect asymptomatic rupture. Screening is costly and often not covered by insurance. The authors assessed awareness of and adherence to these recommendations among patients with silicone breast implants. METHODS: The authors searched electronic medical records for patients aged 18 years or older with silicone breast implants placed between 2011 and 2016. Consenting patients were surveyed by telephone using a standardized script to assess awareness of U.S. Food and Drug Administration recommendations, whether they had undergone magnetic resonance imaging screening, and barriers to testing. Patients who declined to participate or could not be contacted were excluded. Demographics and operative data were collected. Odds ratios were calculated with one-sample 95 percent confidence intervals, and Fisher exact tests of independence were conducted under assumptions of normality. Multivariable logistic regression analysis was performed to test for confounding. RESULTS: Of 370 patients meeting inclusion criteria, 109 consented to participate. Adherence to U.S. Food and Drug Administration recommendations was 5.9 percent (95 percent CI, 0.15 to 28.7 percent). There was no difference in adherence between patients undergoing cosmetic versus reconstructive surgery ( p = 1.00; OR, 0.80; 95 percent CI, 1.17 to 2.93), having health insurance ( p = 0.58), or residing in a county with median annual household income greater than that of the state of residence ( p = 0.33). CONCLUSIONS: A small proportion of respondents had undergone magnetic resonance imaging in accordance with U.S. Food and Drug Administration recommendations. Low adherence highlights a potential limitation of current federal surveillance recommendations. Additional research is needed to better characterize adherence to magnetic resonance imaging surveillance recommendations, identify barriers to implementation, and determine whether this recommendation remains valid.
引用
- Copeland-Halperin LR, Wampler AT, Doughty H, et al. Magnetic Resonance Imaging Screening after Silicone Implant Breast Surgery: Patient Survey of Adherence to U.S. Food and Drug Administration Recommendations. Plast Reconstr Surg. 2022. PMID: 35653512. doi:10.1097/PRS.0000000000009317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。